Related Experiment Video
Updated: Feb 25, 2026

Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System
Published on: May 24, 2017
Effectiveness of continuing nicotine replacement after a lapse: A randomized trial
John R Hughes1, Laura J Solomon2, Catherine E Peasley-Miklus1
1Vermont Center for Behavior and Health, Department of Psychiatry, and Department of Psychological Sciences, University of Vermont, United States.
Instructions to continue nicotine patch after a lapse did not improve smoking cessation success. Most participants who stopped the patch briefly resumed abstinence and patch use, suggesting continued use may not be beneficial.
Area of Science:
- Addiction Medicine
- Behavioral Science
Background:
- Previous analyses suggested continuing nicotine patch use after a lapse aids smoking cessation.
- This study aimed to replicate these findings in a randomized trial.
Purpose of the Study:
- To test if instructing smokers to continue nicotine patch use after a lapse improves abstinence rates.
- To evaluate the impact of lapse management strategies on smoking cessation.
Main Methods:
- 701 smokers attempting to quit were randomized to either continue or discontinue nicotine patch use after a lapse.
- Participants received nicotine patch therapy and phone counseling.
- Instructions were reinforced through multiple communication channels.
Main Results:
- No significant difference in 7-day abstinence at 4 months was observed between groups (51% vs. 46%).
- Most participants (81%) in the discontinue group resumed abstinence and patch use after a short break.
- Adverse events were similar and as expected in both conditions.
Conclusions:
- Instructing smokers to continue nicotine patch use after a lapse did not enhance return to abstinence.
- Similar patch usage in both groups and potential reduced motivation to quit may explain the negative results.
More Related Videos
08:47Spectral Confocal Imaging of Fluorescently tagged Nicotinic Receptors in Knock-in Mice with Chronic Nicotine Administration
Published on: February 10, 2012
14:21Creating Dynamic Images of Short-lived Dopamine Fluctuations with lp-ntPET: Dopamine Movies of Cigarette Smoking
Published on: August 6, 2013
Related Concept Videos
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Longitudinal Research
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Drug Dependence
Oral Drug Delivery Systems: Continuous-Release Systems